Employees: 2,258
Size Hubei Hongyuan Pharmaceutical Technology (301246.SZ) is a China Materials company (Chemicals: Specialty) with a market value of $576M, the 3349th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥14.57 on 18 Nov 2026.
Performance Over six months the shares fell 56.6%, against -26.4% for the median peer and -20.0% for the China market (cap-weighted) — 2nd lowest of 21 in its peer set.
Growth Revenue grew 45.2% over the last twelve months (peer median +21.5%); the operating margin is 12.3% (peer median 7.9%).
Valuation It trades at 1.3× enterprise value to sales against a peer median of 1.7× (8th cheapest of 21).
Capital Return on invested capital runs 0.2 points above its cost of capital (8.3% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥2.56B | CN¥1.94B | CN¥1.77B | CN¥2.05B | CN¥2.06B |
| Revenue growth | — | +9% | -14% | 0% | — |
| Gross profit | CN¥721M | CN¥333M | CN¥199M | CN¥247M | CN¥462M |
| EBITDA | n/a | CN¥323M | CN¥215M | CN¥217M | CN¥356M |
| Net income | CN¥304M | CN¥119M | CN¥51.5M | CN¥87.2M | CN¥435M |
| Free cash flow | -CN¥135M | -CN¥341M | -CN¥115M | -CN¥398M | -CN¥169M |
| Capital expenditure | CN¥258M | CN¥156M | CN¥160M | CN¥475M | CN¥507M |
| Total debt | CN¥1.23B | CN¥1.07B | CN¥857M | CN¥775M | CN¥912M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 301246.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -9.2% | -14.3% | 7th highest of 21 |
| 6-month return | -56.6% | -26.4% | 2nd lowest of 21 |
| Distance from 52-week high | -59.0% | -52.2% | 5th lowest of 21 |
| Revenue growth (TTM) | +45.2% | +21.5% | 4th highest of 21 |
| Operating margin | 12.3% | 7.9% | 8th highest of 21 |
| EV / Sales | 1.3× | 1.7× | 8th cheapest of 21 |
| ROIC minus cost of capital | +0.2 pp | -1.9 pp | 8th highest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Hubei Hongyuan Pharmaceutical Technology 301246.SZ | China | $576M | -57% | +45% | 12% | 1.3× | n/a | n/a |
| Miracll Chemicals 300848.SZ | China | $578M | -46% | +23% | 1% | 2.6× | n/a | n/a |
| DKS 4461.T | Japan | $573M | +3% | +31% | 15% | 1.0× | 7.2% | +7.0% |
| Advanced Nano Products 121600.KS | South Korea | $572M | -11% | +33% | 12% | 5.1× | 27.9% | +18.2% |
| Argus (Shanghai) Textile Chemicals 603790.SS | China | $572M | -30% | +21% | 14% | 3.9× | 10.6% | +0.7% |
| MEC 4971.T | Japan | $582M | -52% | +31% | 32% | 3.2× | 16.1% | +11.9% |
| Tidewater Renewables LCFS.TO | Canada | $567M | +71% | +103% | 25% | 1.7× | -12.6% | +126.4% |
| Zhejiang Jiaao Enprotech Stock 603822.SS | China | $585M | -27% | +101% | 19% | 1.5× | -9.8% | +31.6% |
| Renxin New Material 301395.SZ | China | $587M | +13% | +1% | -6% | 1.8× | n/a | n/a |
| Cybrid Technologies 603212.SS | China | $588M | -40% | -9% | -7% | 1.8× | n/a | n/a |
| Koppers KOP | United States | $563M | -24% | -1% | 9% | 0.8× | -3.9% | +2.4% |
| Jiangsu Lopal Tech 2465.HK | Hong Kong | $590M | -61% | +107% | 7% | 0.9× | n/a | n/a |
| Zanyu Technology 002637.SZ | China | $558M | -40% | -3% | 3% | 0.5× | -1.8% | +11.0% |
| IOL Chemicals & Pharmaceuticals IOLCP.NS | India | $596M | +72% | +27% | 10% | 2.0× | 27.1% | +3.5% |
| Pan Asian Microvent Tech (Jiangsu) 688386.SS | China | $598M | -50% | +12% | 15% | 5.9× | n/a | n/a |
| Hangzhou Gaoxin Materials Technology 300478.SZ | China | $600M | -21% | -21% | -9% | 12.0× | 29.9% | -0.9% |
| Jiangsu Baichuan High-Tech New Materials 002455.SZ | China | $604M | -43% | +9% | 1% | 1.6× | n/a | n/a |
| Kornit Digital KRNT | United States | $549M | -11% | +5% | -16% | 0.9× | n/a | n/a |
| Skchem 285130.KS | South Korea | $548M | -26% | +22% | 0% | 0.8× | n/a | n/a |
| Kanto Denka Kogyo 4047.T | Japan | $546M | -24% | +28% | 18% | 1.4× | n/a | n/a |
| LOTTE Fine Chem 004000.KS | South Korea | $610M | -45% | +18% | 7% | 0.2× | -20.1% | +6.8% |